Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dynastat
2. N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamide
3. N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamine, Sodium Salt
4. N-(((me-p)-p)s)p
5. Parecoxib
1. 198470-85-8
2. Dynastat
3. Parecoxib (sodium)
4. Rayzon
5. Parecoxib Sodium Salt
6. Sc 69124a
7. Parecoxib Na
8. Sc-69124a
9. Parecoxib Sodium [usan]
10. Sodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide
11. Eb87433v6f
12. 197502-82-2
13. Parecoxib Sodium (usan)
14. N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propanamide, Sodium Salt
15. Sodium;[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl-propanoylazanide
16. Ncgc00181773-01
17. Unii-eb87433v6f
18. Dynastat (tn)
19. Dsstox_cid_28596
20. Dsstox_rid_82867
21. N-[4-(5-methyl-3-phenylisoxazol-4-yl)phenylsulfonyl]propionamide, Sodium Salt
22. Dsstox_gsid_48670
23. Mls001424308
24. Schembl117192
25. Chembl296913
26. Dtxsid6048670
27. Parecoxib Sodium [mart.]
28. Parecoxib Sodium [who-dd]
29. Hms2052f09
30. Hms3394f09
31. Hms3886m04
32. Parecoxib Sodium Salt [mi]
33. Bcp06888
34. Tox21_113040
35. Hy-17474a
36. Mfcd04972608
37. S5418
38. Ym-978
39. Akos015951182
40. Sodium (4-(5-methyl-3-phenylisoxazol-4-yl)phenylsulfonyl)(propionyl)amide
41. Am84679
42. Ccg-101177
43. Ccg-268554
44. Cs-1960
45. N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propanamide, Sodium Salt
46. Ac-25455
47. Bp164231
48. Smr000469594
49. Cas-198470-85-8
50. Ft-0673518
51. D03717
52. 470p858
53. A854885
54. J-523328
55. Q27277097
56. Acetamide, 2,2,2-trichloro-n-[3-(trifluoromethyl)phenyl]-
57. Sodium((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide
58. N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propanamide Sodium
59. Propanamide, N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-, Sodium Salt
Molecular Weight | 392.4 g/mol |
---|---|
Molecular Formula | C19H17N2NaO4S |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 392.08067248 g/mol |
Monoisotopic Mass | 392.08067248 g/mol |
Topological Polar Surface Area | 86.6 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 581 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
For the short-term treatment of postoperative pain in adults.
Cyclooxygenase 2 Inhibitors
A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)
M01AH04
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32391
Submission : 2017-12-30
Status : Active
Type : II
Date of Issue : 2020-04-15
Valid Till : 2023-05-19
Written Confirmation Number : WC-0281new2
Address of the Firm :
NDC Package Code : 50379-0022
Start Marketing Date : 2017-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36571
Submission : 2022-01-05
Status : Active
Type : II
Date of Issue : 2022-06-22
Valid Till : 2025-07-28
Written Confirmation Number : WC-0117
Address of the Firm :
NDC Package Code : 65427-017
Start Marketing Date : 2014-07-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2019-07-15
Valid Till : 2020-05-19
Written Confirmation Number : WC-281
Address of the Firm :
NDC Package Code : 50379-0022
Start Marketing Date : 2017-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Powder for solution for infusion
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : Sweden
Brand Name : Dynastat
Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Dosage Strength : 40 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Dynastat
Dosage Form : POWDER FOR SOLUTION FOR INJECTION
Dosage Strength : 20 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Dynastat
Dosage Form :
Dosage Strength : 10 Vials Im Ev 20 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Dyna State
Dosage Form : Powder and liquid to the injection fluid, resolution
Dosage Strength : 40 mg
Packaging : Set
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Dyna State
Dosage Form : Powder for injection fluid, resolution
Dosage Strength : 40 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Dynastat
Dosage Form : Powder for solution for injection
Dosage Strength : 40 mg
Packaging : Vials 10 40mg
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Rayzon 40mg IV/IM
Dosage Form : INJ
Dosage Strength : 40mg/2ml
Packaging : 2X10mg/2ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?